Inogen (INGN) Raises Revenue Guidance Following 3Q Beat; Needham & Company Reiterates Strong Buy
Needham & Company reiterated a Strong Buy rating on Inogen, Inc (NASDAQ: INGN), and raised the price target to $55.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)